Journal of Antivirals & Antiretrovirals
Open Access

Abstract

Anti-Viral Therapy can Prevent Recurrent Hepatocellular Carcinoma Associated with Hepatitis B: Recent Development

Wong SY and Hann HW

Hepatitis B Virus (HBV) infection is one of the major risk factors for the development of Hepatocellular Carcinoma (HCC) in the world. Anti-viral therapy has helped to reduce the incidence of HBV related HCC and curative treatments are available. Recurrent HCC, however, is a dreaded complication. Recent studies have shown that the hepatitis B viral load is a risk factor for recurrence and anti-viral therapy can therefore reduce the incidence of recurrence and improve overall survival. The aim of this article is to review the recent literature on the effect of anti-viral therapy on prevention of recurrence of HBV related HCC.